Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487643 · ClinicalTrials.gov registry record
Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay
A clinical trial, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00487643 is a clinical trial that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT00487643 has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Purpose: to build a library of normal tear lacritin values by collecting tears from normal adult human subjects and to develop a non-invasive clinical assay for lacritin. Such an assay will provide more sensitive indicators of eye disease for clinicians and determine if a particular therapy, such as recombinant lacritin drops, is of benefit.
Interventions
- PROCEDURE Tear Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-05 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00487643
The ClinicalTrials.gov registry entry for NCT00487643 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tear Collection is the first listed.
NCT00487643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00487643 about?
NCT00487643 is a clinical study titled "Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay". Purpose: to build a library of normal tear lacritin values by collecting tears from normal adult human subjects and to develop a non-invasive clinical assay for lacritin. Such an assay will provide more sensitive indicators of eye disease for clinicians and determine if a particular therapy, such as...
What is the current status of trial NCT00487643?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-05. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00487643?
The interventions under investigation include: Tear Collection (PROCEDURE).
Who is sponsoring clinical trial NCT00487643?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.